ScholarIQanswers from OpenAlex

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

PaperCitations, authors & open-access status

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity have?

ScholarIQcitation count

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity has 697 citations in the OpenAlex counts ScholarIQ stores.

When was Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity published?

ScholarIQyear

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity has 2013 year in the ScholarIQ index.

What is the open-access status of Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity?

ScholarIQoa status

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity has bronze oa status in the ScholarIQ index.

What is the DOI of Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity?

ScholarIQdoi

The DOI for Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity is on the source record.

What is the PMID of Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity?

ScholarIQpmid

The PMID for Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity is on the source record.

What is the OpenAlex record for Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity?

ScholarIQopenalex

The OpenAlex for Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial